FSSAI moves against Nestlé over baby formula claims and biotin test

“We confirm our adherence to regulations, including norms and label declarations as per laws. We will continue to work closely with FSSAI,” the spokesperson added.

The Food Safety and Standards Authority of India (FSSAI) has initiated three separate cases against Nestlé India over alleged regulatory violations involving its infant nutrition products.

Two cases relate to promotional claims made for NAN Excella Pro Stage 1 and Lactogen Pro 1, while the third concerns a sample of Nestlé’s follow-up formula that the regulator found to have non-conforming levels of biotin.

The action follows the FSSAI’s examination of the products and promotional material available on e-commerce platforms. The regulator has raised concerns about claims made for the two infant formula products and about the nutritional composition of the follow-up formula sample.

Legal action initiated against Nestle India Ltd over several non-compliances pertaining to the FSS Act.
FSSAI remains committed to strengthening the food safety ecosystem through its enforcement actions. #FSSAINotice #FSSAIAction pic.twitter.com/gG1k6noK0X

— FSSAI (@fssaiindia) September 18, 2026

What did FSSAI flag?

For NAN Excella Pro Stage 1, the FSSAI flagged claims relating to whey protein and five human milk oligosaccharides (HMOs), complex sugars naturally present in human breast milk. In the case of Lactogen Pro 1, the regulator raised concerns over a claim relating to whey protein, including its digestibility.

The FSSAI said such promotional claims are not permitted under India’s regulations governing foods for infant nutrition. The rules prohibit pictures, graphics or phrases intended to increase the saleability of infant milk substitutes or infant food. They also prohibit terms such as “Humanised” and “Maternalised”, as well as similar expressions.

The restrictions are part of a broader regulatory framework governing the marketing of infant milk substitutes in India.

The development has been welcomed by Dr Arun Gupta, chief coordinator of the Breastfeeding Promotion Network of India (BPNI) and one of the people involved in efforts surrounding the IMS Act. “This is a very encouraging development; they should pursue these cases,” Gupta said.

Story continues below this ad

He said regulatory action was important because complaints relating to the promotion of infant formula had been made in the past, but did not always result in proceedings. “Nestlé certainly is one of the bigger producers of infant formula and this also sends a signal to the other companies to follow suit,” he said.

Why are infant formula advertisements so tightly regulated?

India has had restrictions on the promotion of infant milk substitutes for decades. The Infant Milk Substitutes, Feeding Bottles and Infant Foods (Regulation of Production, Supply and Distribution) Act, 1992, commonly known as the IMS Act, places restrictions on advertising and promotion of such products.

The law is intended to prevent marketing practices that could undermine breastfeeding or create the impression that infant milk substitutes are equivalent or superior to breast milk.

The FSSAI has cited both the Food Safety and Standards (Foods for Infant Nutrition) Regulations, 2020 and the IMS Act in the action against Nestlé.

Separate concern over biotin

Story continues below this ad

The third case concerns a follow-up formula; a product intended for older infants and children after the initial infant-formula stage. The FSSAI said a sample was found to be non-conforming with respect to its biotin content. Biotin, also known as vitamin B7, is a water-soluble vitamin involved in several metabolic processes.

The regulator said the sample was sent for re-analysis and that the referral laboratory also found it to be non-conforming. According to the applicable standards cited in the proceedings, infant food is required to contain 7.5 to 50 micrograms of biotin. The finding led to a separate case against Nestlé.

Nestlé says products comply with regulations

Nestlé India has said that its products comply with applicable regulations. The company has also indicated that the labels under scrutiny had been scientifically validated and approved by the FSSAI’s expert committee, and that it has submitted a detailed response to the regulator.

The company’s position is significant because the FSSAI proceedings are still at the regulatory stage. The initiation of a case does not by itself establish a final violation or mean that a penalty has already been imposed.

Why the scrutiny matters

Story continues below this ad

Infant formula occupies a particularly sensitive area of food regulation because decisions about infant feeding have implications for both nutrition and breastfeeding practices. The latest action also comes amid increased scrutiny of infant nutrition products and their marketing. A 2024 investigation by Swiss NGO Public Eye reported differences in the sugar content of some Nestlé infant formula and baby-food products sold in lower-income countries, including India, compared with products sold in European markets.

Nestlé has previously maintained that its products comply with applicable Indian regulations and standards. The three cases initiated by the FSSAI will now go through the regulatory process. Their outcome will determine whether any violations are established and what action, if any, follows.

Anonna Dutt is a Principal Correspondent who writes primarily on health at the Indian Express. She reports on myriad topics ranging from the growing burden of non-communicable diseases such as diabetes and hypertension to the problems with pervasive infectious conditions. She reported on the government’s management of the Covid-19 pandemic and closely followed the vaccination programme. Her stories have resulted in the city government investing in high-end tests for the poor and acknowledging errors in their official reports. Dutt also takes a keen interest in the country’s space programme and has written on key missions like Chandrayaan 2 and 3, Aditya L1, and Gaganyaan. She was among the first batch of eleven media fellows with RBM Partnership to End Malaria. She was also selected to participate in the short-term programme on early childhood reporting at Columbia University’s Dart Centre. Dutt has a Bachelor’s Degree from the Symbiosis Institute of Media and Communication, Pune and a PG Diploma from the Asian College of Journalism, Chennai. She started her reporting career with the Hindustan Times. When not at work, she tries to appease the Duolingo owl with her French skills and sometimes takes to the dance floor. ... Read More